logo
Southern California healthcare agencies fear cuts to HIV prevention will cost lives

Southern California healthcare agencies fear cuts to HIV prevention will cost lives

Yahoo29-03-2025

Statements from the Trump administration that officials are considering cuts to key programs for the prevention of HIV and AIDS are generating outrage among two of the largest LGBTQ+ service organizations in Southern California.
Leaders of the LGBT Center in Los Angeles and DAP Health in the Coachella Valley said that a sharp cut in the Centers for Disease Control and Prevention's Division of HIV Prevention could endanger many lives and potentially drive up the long-term cost to taxpayers, if incidence of the virus that causes AIDS increases.
When the Wall Street Journal first broke news of the potential cut in mid-March, a spokesman said no 'final decision' had been made 'on streamlining CDC's HIV Prevention Division.'
Asked this week for an update, CDC spokesman Nicholas Spinelli referred questions to the agency's parent organization, the Department of Health and Human Services, which did not respond. The White House also did not respond to a request for comment Friday.
Read more: RFK Jr. makes sweeping cuts in federal health programs, including CDC, FDA
Health agencies across the nation have helped drive down the incidence of HIV, largely through testing, counseling and the distribution of medications that prevent the spread of the disease. Much of the funding for that work came from the Centers for Disease Control and Prevention. The rate of decline was 12% nationally between 2018 and 2022, with an even sharper 21% in the 50 local areas where the CDC focused its prevention efforts.
The LGBT Center in Los Angeles, which provides outreach, testing and HIV-preventative medications, said it has been left in limbo about what will become of its $450,000 CDC grant to support that work.
'We have seen tremendous gains in the fight to end HIV because of the real investments that have been made in prevention and care,' said Joe Hollendoner, CEO of the LGBT Center. 'We've even been talking about how, in our lifetime, we could end the HIV epidemic and get to zero new cases.'
'But if we are terminating HIV prevention contracts in the way that we anticipate ... it is not hyperbole to say it's going to cost human lives.'
That echoed concerns voiced by DAP Health, which operates 25 clinics in Riverside and San Diego counties, including many in the Coachella Valley, which has a large gay population and where the HIV rate is four times the national average.
'This 'cost-saving' strategy of decimating the CDC's HIV prevention program will only increase costs, both human and financial,' David Brinkman, the CEO of DAP Health, said in a statement.
Brinkman pointed to research that showed the average cost of lifetime treatment for a patient who contracts HIV to be about $500,000 a year. The estimated potential 'savings' of $1.8 billion if the federal disease agency eliminates the HIV program would quickly disappear if more than 3,600 Americans were newly infected, Brinkman said, adding: 'And we know the toll of lives impacted by HIV with this slashing will be in the tens of thousands."
Read more: Utah becomes the first state to ban fluoride in public drinking water
An outspoken voice against a possible reduction or elimination of the anti-HIV program is Rep. Raul Ruiz (D-Palm Desert), a former emergency room doctor who represents the Coachella Valley.
'The CDC's Division of HIV Prevention plays a vital role in reducing new infections, saving billions in preventable health care costs, and ensuring that individuals can access life-saving medication,' Ruiz said in a statement.
Ruiz noted that the CDC program also plays a central role in responding to viral hepatitis and TB. The congressman joined 100 other Democrats in the House and Senate in sending a letter to President Trump, urging him to reconsider any plan to reduce or eliminate the disease prevention program.
The lawmakers reminded Trump that during his first term, in 2019, he declared the goal of ending the HIV epidemic. 'One of the pillars of your initiative, as shown on CDC's website, is prevention,' the letter said. 'It is imperative that you uphold this commitment.'
C.J. Tobe, chief transformation officer for DAP Health, said the Trump administration's potential change of course seemed inexplicable.
'It's a 180-degree turn, to threaten to take this away,' Tobe said. 'It feels personal and it makes zero sense.'
Confusion and turmoil have also enveloped U.S. government-supported research around HIV.
CNN reported this week that the National Institutes of Health had eliminated funding for dozens of HIV-related research grants. The news outlet cited a Department of Health and Human Services database and quoted scientists who said the cuts would also deal a crippling blow to the goal of ending HIV.
Read more: Deadly, drug-resistant fungus CDC calls 'urgent threat' is spreading in hospitals
Among those on the chopping block were grants related to PrEP, the regimen of drugs that can thwart HIV infection, scientists told the New York Times.
Funding for intervention against the disease overseas also appeared endangered when the Trump administration froze foreign aid and then all but eliminated the U.S. Agency for International Development, the main American agency for delivering assistance to other countries.
A study published in the Lancet said that a reduction in support from the U.S. and other major funding countries could lead to 4.4 million to 10.7 million new HIV infections worldwide by 2030, killing 770,000 to nearly 3 million more people.
'Unmitigated funding reductions could significantly reverse progress in the HIV response by 2030, disproportionately affecting sub-Saharan African countries and key and vulnerable populations,' the study said.
Sign up for Essential California for news, features and recommendations from the L.A. Times and beyond in your inbox six days a week.
This story originally appeared in Los Angeles Times.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Nucleus Genomics Launches Nucleus Embryo, Genetic Optimization Software Alongside Partnership with Genomic Prediction
Nucleus Genomics Launches Nucleus Embryo, Genetic Optimization Software Alongside Partnership with Genomic Prediction

Yahoo

time3 hours ago

  • Yahoo

Nucleus Genomics Launches Nucleus Embryo, Genetic Optimization Software Alongside Partnership with Genomic Prediction

Parents pursuing IVF now have a new level of choice to empower their family planning NEW YORK, June 4, 2025 /PRNewswire/ -- With U.S. birthrates plummeting and IVF on the rise, Nucleus Genomics today launched Nucleus Embryo, the first genetic optimization software that lets parents see and understand a complete genetic profile to select an embryo. "Before there's a heartbeat, there's DNA," said Kian Sadeghi, founder and CEO of Nucleus. "One file containing DNA and genetic markers can tell you more about your baby's future than any other test a doctor could possibly run at this stage. Most clinics stop at whether an embryo will develop. For many parents, that's not enough. Patients have long asked for more transparency from clinics, and Nucleus Embryo is an important step toward complete data ownership for parents planning their families." The software enables parents to analyze and compare up to 20 embryos across over 900 hereditary conditions and 40 additional analyses beyond basic viability, spanning cancers, chronic conditions, appearance, cognitive ability, mental health, and more. To widen access to the software, Nucleus will partner with Genomic Prediction, the first company to offer genome-wide screening on embryos. The partnership sets a new standard in genetic medicine, continuing Genomic Prediction's decade-long history of giving hopeful parents the best possible chance of implanting healthy embryos. The company's analyses focus on hereditary conditions, acting as the first line of defense against chronic and rare diseases. "As an organization, we are committed to supporting patients' rights to their DNA and any information that can aid in their family-building journey," said Kelly Ketterson, CEO of Genomic Prediction. "We have a legacy of innovation aimed at providing patients with access to the best scientific resources. Our partnership with Nucleus opens access to information our patients have requested and allows us to uphold our commitment to this legacy." Nucleus' partnership with Genomic Prediction reflects a growing shift in how parents think about genetics as a tool to give children the best possible start in life. A wide-ranging study of Americans found the majority accepted the use of genetic technology to choose embryos based on health and personality traits. Four in 10 parents would use genetic optimization as another tool to understand their future child's cognitive abilities. Most women undergo three to six IVF cycles before successfully having a baby, with each cycle costing up to $25,000. Many embryos are unviable within days of being fertilized, leaving parents with few to choose from. Facing high stakes, clinicians often recommend genetic testing to optimize a couple's chances of a healthy pregnancy. But these tests typically stop at a select number of hereditary conditions and chromosome count. Now, advanced genetic analysis from Nucleus gives parents a new window into the health and well-being of their future child. Nucleus Embryo provides a comprehensive genetic profile for each embryo, encompassing hereditary genetic diseases, like cystic fibrosis and hemochromatosis, alongside genetic measures of cognitive ability, mental health, and risk for chronic diseases. Wide access to genetic insights for embryos can also help extend lifespan from the earliest stages of life. While more than half of all deaths annually in the U.S. are attributed to chronic, age-related conditions — such as Alzheimer's disease, diabetes, cancer, and heart disease — research shows embryonic selection can materially help reduce disease risk for these conditions. "We celebrate health optimization and the pursuit of longevity in every other part of life via our focus on training, supplements, and sleep," Sadeghi said. "We all know health isn't just the absence of disease. It's the ability to understand our bodies and genetic makeup to reach our full potential. Now we can apply this principle to life's inception." About Nucleus Genomics Nucleus builds software for generational health. Inspired by the loss of his cousin who died of a rare — yet preventable — genetic disease, Nucleus founder and Thiel Fellow Kian Sadeghi left an Ivy League university to build a product that could have saved her life. Our advanced DNA health test and analysis takes the guesswork out of your health, whether it's perfecting your protocols, knowing your risk for cancer, or planning for a healthy family. Follow us on social media @nucleusgenomics. About Genomic Prediction Genomic Prediction, Inc. is the frontrunner in advanced embryo screening. Our proprietary LifeView platform is state-of-the-art technology that assesses embryos for genetic health aimed at improved IVF outcomes. The LifeView Embryo Health Score Test (EHS) offers insight into the likelihood of developing conditions driven by multiple genes. It tests for significant health issues, including cardiovascular disease, diabetes mellitus, certain cancers, and mental health conditions. The EHS results are derived from the same embryo sample used in the following PGT tests: PGT-A: Identifies chromosome abnormalities in embryos. PGT-A+: Pinpoints the origin (paternal, maternal, or embryonic) of chromosome abnormalities. PGT-M: Decreases the chances of passing on monogenic (single-gene) conditions. PGT-SR: Detects chromosome abnormalities and structural imbalances, providing clarity between normal and balanced chromosomes. View original content to download multimedia: SOURCE Nucleus

Oakland County issues alert for measles exposure site in Rochester Hills
Oakland County issues alert for measles exposure site in Rochester Hills

Yahoo

time4 hours ago

  • Yahoo

Oakland County issues alert for measles exposure site in Rochester Hills

FOX 2 - The Oakland County Health Division is notifying the public about a Rochester Hills measles exposure site involving a person from another county. The exposure site is a medical office building at 3950 S. Rochester Road at the corner of South Boulevard on Tuesday, June 3, according to a release from the Oakland County Health Division. Anyone there between 8 a.m. and 7:30 p.m. may have been exposed to measles. If you think you were exposed to measles at this location on June 3, Immune Globulin (IG) treatment is effective within six days of exposure for high-risk individuals. Those considered high-risk include women who are pregnant, unvaccinated children under age 5 and those who have a weakened immune system due to illness and disease including diabetes or HIV, malnutrition and/or medications. If you are not eligible for IG, monitor symptoms through June 24. If symptoms develop, call ahead to your health care provider. Individuals born in or before 1957 are considered immune. Measles is a highly contagious, vaccine-preventable disease that is spread by direct person-to-person contact and through the air. The Health Division recommends unvaccinated individuals ages 1 year and older receive a measles vaccination to protect themselves and those around them. Anyone who doesn't have a record of two MMR vaccines, unsure if they've have been vaccinated, or unsure if you've had measles in the past, needs to contact their health care provider. Measles can live for up to two hours in the air where an infected person coughed or sneezed. Symptoms of measles usually begin 7-14 days after exposure, but can appear up to 21 days after exposure, and may include: High fever (may spike to over 104°F Cough Runny nose Red, watery eyes (conjunctivitis) Tiny white spots on the inner cheeks, gums and roof of mouth (Koplik Spots) 2-3 days after symptoms begin. A rash that is red, raised, blotchy; usually starts on face, spreads to trunk, arms and legs 3-5 days after symptoms begin. The MMR vaccine is available through some health care providers, Oakland County Health Division offices in Southfield and Pontiac, and many pharmacies. Health Division offices are located at the following addresses: North Oakland Health Center, 1200 N. Telegraph Road, Building 34 East, Pontiac South Oakland Health Center, 27725 Greenfield Road, Southfield. Health Division clinics hours are Monday, Wednesday and Friday 8:30 a.m. – 5 p.m. Tuesday 9:30 a.m. – 6 p.m. and Thursday 7:30 a.m. – 5 p.m. Visit for more information on measles, or contact Nurse on Call, 8:30 a.m. to 5 p.m. Monday through Friday, at 800-848-5533 or noc@

Pharmaceutical company AstraZeneca sues Utah Attorney General over discount medication law
Pharmaceutical company AstraZeneca sues Utah Attorney General over discount medication law

Yahoo

time4 hours ago

  • Yahoo

Pharmaceutical company AstraZeneca sues Utah Attorney General over discount medication law

SALT LAKE CITY () — The pharmaceutical company AstraZeneca has filed a federal lawsuit against Utah Attorney General Derek Brown and Utah Insurance Commissioner Jon Pike over a recent law that is intended to allow more pharmacies to have access to drug discount programs. In a lawsuit filed May 23, AstraZeneca alleges that Utah SB 69 is unconstitutional. The law was introduced and passed in the 2025 General Assembly, and it went into effect on May 7. The law prohibits drug manufacturers from restricting pharmacies from working with 340B entities, which help pharmacies and patients access medications at a discounted price. Senator Lee responds to the Trump-Musk feud The 340B Drug Pricing Program is a that 'enables covered entities to stretch scarce federal resources as far as possible, reaching more eligible patients and providing more comprehensive services,' according to the Health Resources and Services Administration (HRSA) website. It means that drug manufacturers participating in Medicaid agree to provide 'outpatient drugs to covered entities at significantly reduced prices.' All organizations need to be registered and enrolled in the 340B program in order to purchase discounted medications. The law that established the 340B Program, Section 340B(a)(4) of the Public Health Service Act, specified certain types of for the program, such as medical centers that serve rural and other underserved communities and clinics that specialize in particular diseases like HIV/AIDS. SB 69 expands the scope, requiring drug manufacturers to provide the discounts to third-party pharmacies that are contracting with 340B entities, and this is what AstraZeneca is claiming is unconstitutional in its lawsuit. Utah House Republicans elect new leadership members The lawsuit states that because price controls 'disincentivize innovation and destabilize markets,' Congress chose to specifically limit the types of organizations that are eligible in Section 340B. The suit notes that for-profit pharmacies like Walgreens or CVS were not included as eligible, and there have already been several federal court cases ruling that block efforts to require drug manufacturers to provide discounts to contracted pharmacies. AstraZeneca claims in its suit that SB 69 'requires pharmaceutical manufacturers to offer 340B-discounted pricing for sales at an unlimited number of contract pharmacies,' expanding 340B discounts to 'an entirely new category of transactions not covered by Section 340B itself.' The suit alleges that SB 69 directly conflicts with federal law requirements, and therefore, it cannot be enforced against Astrazeneca or other drug manufacturers. AstraZeneca is asking the court to declare SB 69 unconstitutional and to order that Utah AG Derek Brown and Insurance Commissioner Jon Pike not enforce the law against AstraZeneca. Musk floats 'The American Party' after Trump tiff Myths VS Facts: What health officials want you to know about the MMR vaccine Good4Utah Road Tour: Willard Bay State Park Lori Vallow Daybell back in court, charged with conspiracy to murder ex nephew-in-law Man charged with assault for allegedly attacking and strangling neighbor Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store